2017 Annual Meeting | C142 - Pediatric MS: Diagnosis and Treatment

Date Tuesday 04/25/17

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) John W. Rose, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should know the clinical and MRI parameters of pediatric demyelinating diseases, understand diagnosis of pediatric MS and related disorders, differentiate pediatric demyelinating diseases, understand the current treatment options, know the emerging environmental factors, know the status of clinical trials in pediatric MS, and understand how to access continuing education/discussion specific for pediatric MS.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:30 PM - 03:35 PM	Luncheon	Introduction John W. Rose, MD, FAAN
03:35 PM - 04:20 PM	Speaker	Diagnosis of Pediatric MS Teri Schreiner, MD, MPH, FAAN
04:20 PM - 04:30 PM	Q&A	Questions and Answers
04:30 PM - 05:20 PM	Speaker	Treatment of Pediatric MS Emmanuelle Waubant, MD, PhD, FAAN
05:20 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Teri Schreiner, MD, MPH, FAAN	The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��